• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IN8bio, Inc. - Common Stock (NQ:INAB)

2.441 +0.041 (+1.72%)
Streaming Delayed Price Updated: 2:29 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about IN8bio, Inc. - Common Stock

William Ho, CEO of In8bio Inc. (NASDAQ: INAB), to Present at NobleCon20
November 08, 2024
Via Investor Brand Network
News headline image
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 09, 2024
From IN8bio, Inc
Via GlobeNewswire
News headline image
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
April 30, 2024
From IN8bio, Inc
Via GlobeNewswire
News headline image
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
April 24, 2024
From IN8bio, Inc
Via GlobeNewswire
IN8bio Inc. (NASDAQ: INAB) Near the Top of Equities by Percentage Gain on 4/24
April 24, 2023
Via Investor Brand Network
News headline image
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
April 16, 2024
From IN8bio, Inc
Via GlobeNewswire
News headline image
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
April 09, 2024
From IN8bio, Inc
Via GlobeNewswire
News headline image
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
March 14, 2024
From IN8bio, Inc
Via GlobeNewswire
News headline image
IN8bio to Present at Upcoming Investor Conferences
February 26, 2024
From IN8bio, Inc.
Via Business Wire
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June
May 31, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:JAZZ),(NASDAQ:GERN),(NASDAQ:INAB),(NASDAQ:VCYT) EQNX::TICKER_END 
Via FinancialNewsMedia
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap